% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Bouzaki:305363,
author = {A. Bouzaki and E. Vasquez Osorio and S. Kerns and M. van
Herk and A. Morris and J. Shortall and D. Azria and M.-P.
Farcy-Jacquet and J. Chang-Claude$^*$ and A. Choudhury and
A. Dunning and M. Lambrecht and B. Avuzzi and D. De
Ruysscher and P. Seibold$^*$ and E. Sperk and C. Talbot and
A. Vega and L. Veldeman and A. Webb and B. Rosenstein and C.
West and T. Rancati and E. Gioscio and A. McWilliam},
title = {{I}ntegration of dose surface maps and genetic data
identifies the lower posterior rectum as a key region for
toxicity after prostate cancer radiotherapy.},
journal = {Clinical cancer research},
volume = {nn},
issn = {1078-0432},
address = {Philadelphia, Pa. [u.a.]},
publisher = {AACR},
reportid = {DKFZ-2025-02107},
pages = {nn},
year = {2025},
note = {epub},
abstract = {Genome-wide association studies (GWAS) are the gold
standard for identifying single-nucleotide polymorphisms
(SNPs) associated with rectal toxicity after prostate cancer
radiotherapy. However, they often neglect the radiotherapy
dose distribution, which is a key contributor to toxicity
risk. Here we combined rectal dose surface maps with genetic
data to identify rectal regions where variants influence
dose-toxicity relationships.Data was analysed from 1,293
prostate cancer patients from the REQUITE study. Deep
learning rectum contouring ensured consistent segmentation
and rectum lengths were standardised to generate 2D dose
surface maps. Patients were categorized based on the
presence of risk alleles for three candidate SNPs
(rs1801516, rs17055178, rs17630638). Propensity score
matching accounted for age, rectal volume, prostate volume,
and hormone therapy. Voxel-wise Cox Proportional Hazards
Models (CPHM) with permutation testing assessed
dose-toxicity associations.Voxel-wise CPHM revealed
significant (p < 0.05) dose-toxicity associations in risk
allele carriers for all SNPs for bowel urgency. Risk regions
were consistently in the lower posterior rectum. Higher risk
of acute bowel control was identified among carriers of the
risk allele for rs17630638. For this SNP, carriers of the
risk allele showed higher risk for and late rectal bleeding,
but reduced risk for acute rectal bleeding.This study
identified genotype-driven toxicity patterns using spatial
dose mapping. By revealing consistent high-risk rectal
regions, this approach strengthens the link between genomics
and radiotherapy planning. Importantly, modern radiotherapy
planning makes it feasible to reduce dose in genetically
sensitive patients and move toward more personalised
treatment.},
cin = {C020},
ddc = {610},
cid = {I:(DE-He78)C020-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41081635},
doi = {10.1158/1078-0432.CCR-25-2102},
url = {https://inrepo02.dkfz.de/record/305363},
}